Logo

Mini-cPIE (COVID-19 vaccination IAR) – What is it and how to conduct one? - Shared screen with speaker view
Terri Hyde, CDC
30:40
CDC
Carla Lee
30:45
CDC
Adriana Almiñana
30:51
JSI
Shibani Kulkarni
30:52
CDC
Rashmi Mehra
30:56
JSI
Ledor Igboh
31:03
CDC
LUCIANO ABRAHAM
31:05
WHO
André Tonda
31:15
JSI
Lisa Oot
31:23
JSI
Molly Chen
31:34
RTI International
Meg McCarron
31:37
CDC
Sergio Loayza Saldivia
31:37
PAHO
Carsten Mantel
32:46
MMGH Consulting
Svetlana Stefanet
33:10
UNICEF EACRO
Gillian Mayers - Advisor MMGH
33:16
MMGH Consulting
Thomas Cherian
36:13
MMGH consulting
Akif Saatcioglu
01:03:06
Please share the videos and slides, thanks
Ousmane Dia
01:04:04
Before IARs are shared globally, Is there a validation process?
Jessica Shearer (she/her)
01:04:05
Thanks for the great overview. Considering the fast pace of rollout, and the real-time observation of many barriers and bottlenecks, is there any recommendation to take a more prospective and real-time approach to documenting challenges and responding to them?
Jenny Walldorf
01:06:30
To respond to the question on a validation process. There is no specific validation process in place. We encourage sharing of as much detail as possible for peer learning at the discretion of the country.
MAYIGANEL
01:11:33
The only validation is at country level. Countries may wish to share full IAR reports and part of the reports (executive summaries). We will talk about it later in the webinar.
MAYIGANEL
01:19:39
@Jessica: Sure, the IAR encourages both a retrospective look of the response and prospective look. The prospective look is through the identification of critical actiions for remediation and improvement measures (recommendations) for immediate (shorterm - quick fixes, quick wins), mid-term and long term action.... the mid/long term recommendations are more aligned with health systems strengthening and (country) capacity capacity building
LUCIANO ABRAHAM
01:20:51
No
Lora Shimp, JSI
01:25:30
Countries will most likely need assistance to apply the IAR findings as quickly and seamlessly as possible for mid-course adjustments. Often, PIEs have been perceived as 'externally driven' and then 1-2 years after introduction, there are no resources to address gaps. We have a much compressed timeframe with COVID-19 vaccination, so how can we quickly resource implementation of IAR findings??
Jenny Walldorf
01:29:22
@LoraShimp. Perhaps we can address this in the discussion. Are you asking about resources in terms of funds for the follow up activities?
Liviu Vedrasco
01:36:50
here is the link to the Global Fund COVID-19 response funding mechanism https://www.theglobalfund.org/en/covid-19/response-mechanism/
Lora Shimp, JSI
01:38:53
@Jenny - Yes, human, financial and operational resources to implement actions based on the IAR and mini-PIEs. We often raise the issues but then countries have insufficient resources to follow-up. We know with other NVIs, that sometimes VIG funds can be used for 1-2 years post-launch. What resources are available for C-19 vaccination to implement operational adjustments?
Dr Traoré S Martin
01:44:15
Please share the slides of Botswana IAR with us
Akif Saatcioglu
01:45:53
Not every country is GF/GAVI is eligible
Akif Saatcioglu
01:47:25
Not eligible
Akif Saatcioglu
01:47:35
I am WCO
Cindy Chiu de Vázquez (WHO HQ)
01:50:23
IAR and COVID-19 vaccination IAR (mini-cPIE) are country-owned and country-led process, so countries can decide how they decide to plan their mini-cPIEs
Cindy Chiu de Vázquez (WHO HQ)
01:50:57
Countries should tailor the tools provided to their specific contexts
MAYIGANEL
01:51:03
There are many partner organizations that are ,interested to support the IAR conduct and post-IAR follow up including the implementation of recommendations. those partners include Resolve to Save Lives (RTSL), CDC...
MAYIGANEL
01:53:10
Please do not hesitate to reach out to us when and if you plan to conduct the mini-cPIE. We will be more than happy to support and advice on funding sources.
Jenny Walldorf
01:53:42
In terms of resources for country implementation/follow-up, we at WHO plan to coordinate among interested partners who plan to support countries. We are compiling a list of country plans for mini and classic PIEs
Rebecca Fields, JSI, Washington
01:55:52
Given the "lite" nature of the IAR (1/2 to 2-3 days), the number of questions must be limited, especially if root cause analysis is to be done well. While new issues will need to be addressed as they emerge, what is the guidance to countries regarding tracking the same questions over time to monitor progress? This runs up against time constraints.
Lora Shimp, JSI
01:55:56
Thanks! Perhaps we can have a follow-up session on how countries like Botswana and other, larger LICs have resourced implementation post-IAR/mini-PIE?
Lora Shimp, JSI
01:59:53
Thanks and good weekend!
Youssouf Sawadogo
02:00:01
Merci a toutes et a tous